The said drug is equivalent to reference listed drug, Zithromax tablets. Azithromycin is indicated to treat certain bacterial infections such as bronchitis, pneumonia, sexually transmitted diseases (STD), infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.
The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad (India).
Azithromycin tablets USP, 500 mg had annual sales of $20 million in the United States (IQVIA MAT February. 2023).
As on 31 December 2022, the group has 360 approvals and has so far filed over 440 ANDAs since the commencement of the filing process in FY 2003-04.
Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.
The company's consolidated net profit jumped 24.5% to Rs 622.90 crore on 17.9% rise in net sales to Rs 4,159.80 crore in Q3 FY23 over Q3 FY22.
The scrip rose 0.50% to Rs 496.45 on the BSE.
|